BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-30 Cr | ₹-21 Cr | ₹-25 Cr | ₹-24 Cr | ₹-21 Cr |
What is the latest Cash Flow from Financing Activities ratio of BLISS GVS PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-30 Cr |
| Mar2024 | ₹-21 Cr |
| Mar2023 | ₹-25 Cr |
| Mar2022 | ₹-24 Cr |
| Mar2021 | ₹-21 Cr |
How is Cash Flow from Financing Activities of BLISS GVS PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-30 Cr | Negative | |
| Mar2024 | ₹-21 Cr | Negative | |
| Mar2023 | ₹-25 Cr | Negative | |
| Mar2022 | ₹-24 Cr | Negative | |
| Mar2021 | ₹-21 Cr | - | |
Compare Cash Flow from Financing Activities of peers of BLISS GVS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLISS GVS PHARMA | ₹1,894.3 Cr | 22.2% | 9.8% | 3.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,131.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,862.0 Cr | 2.8% | 2.2% | 10.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,254.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹121,198.0 Cr | 0.8% | 0.1% | 3.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,083.0 Cr | 0.4% | 3.2% | 0.3% | Stock Analytics | |
BLISS GVS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLISS GVS PHARMA | 22.2% |
9.8% |
3.4% |
| SENSEX | 1% |
0.3% |
6.7% |
You may also like the below Video Courses